Li Malmberg
Keine laufenden Positionen mehr
Profil
Li Malmberg is a professional who has held several positions in the biotechnology industry.
She was the Director & Head-Process Sciences at AbbVie, Inc., the VP-Biologics Development & Manufacturing at Celgene Corp., the Chief Technology & Manufacturing Officer at Xilio Therapeutics, Inc., and the Senior Vice President-CMC at Magenta Therapeutics, Inc. Malmberg received her undergraduate degree from the University of Illinois and her doctorate from the University of Minnesota Twin Cities.
Ehemalige bekannte Positionen von Li Malmberg
| Unternehmen | Position | Ende |
|---|---|---|
| CELGENE | Corporate Officer/Principal | - |
| XILIO THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
| ABBVIE INC. | Corporate Officer/Principal | - |
| MAGENTA THERAPEUTICS | Corporate Officer/Principal | - |
Ausbildung von Li Malmberg
| University of Minnesota Twin Cities | Doctorate Degree |
| University of Illinois | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| XILIO THERAPEUTICS, INC. | Health Technology |
| ABBVIE INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
